Lamivudine/nevirapine/stavudine
Lamivudine/nevirapine/stavudine (3TC/NVP/d4T) is a fixed-dose combination medication used to treat HIV/AIDS.[1] It contains lamivudine, nevirapine, and stavudine.[1] It is either used by itself or along with other antiretrovirals.[1] It is taken by mouth twice a day.[1]
Combination of | |
---|---|
Lamivudine | nucleoside reverse transcriptase inhibitor |
Nevirapine | non-nucleoside reverse transcriptase inhibitor |
Stavudine | nucleoside reverse transcriptase inhibitor |
Clinical data | |
Trade names | Triomune, others |
ATC code | |
Identifiers | |
ChemSpider |
|
It is on the World Health Organization's List of Essential Medicines.[2] As of 2015, it is not commercially available in the United States.[3]
Medical uses
It is a common first line treatment in the developing world.[4]
Adverse effects and safety
The medication is generally well tolerated.[5] Side effects are those of the underlying medications.[1] This may include rash, numbness, pancreatitis, and high blood lactate levels.[5] Use is not recommended in those with significant liver problems.[5] It is unclear if use in pregnancy is safe for the baby and recommendations include starting in the second trimester if possible.[5]
References
- World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. p. 160. hdl:10665/44053. ISBN 9789241547659.
- World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
- Kasper, Dennis L.; Fauci, Anthony S.; Hauser, Stephen; Longo, Dan; Jameson, J. Larry; Loscalzo, Joseph (2015). Harrison's Principles of Internal Medicine 19/E (Vol.1 & Vol.2). McGraw Hill Professional. p. 1277. ISBN 9780071802161. Archived from the original on 2016-12-20.
- Siegfried, NL; Van Deventer, PJ; Mahomed, FA; Rutherford, GW (19 April 2006). "Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults". The Cochrane Database of Systematic Reviews (2): CD004535. doi:10.1002/14651858.CD004535.pub2. PMID 16625606.
- "Nevirapine/stavudine/lamivudine" (PDF). aidsmap. Archived from the original (PDF) on 20 December 2016. Retrieved 18 December 2016.
External links
- "Lamivudine mixture with Nevirapine and Stavudine". Drug Information Portal. U.S. National Library of Medicine.